par Yourassowsky, Eugène 
;Vander Linden, M.P.
Référence Arzneimittel-Forschung, 26, 2, page (184-185)
Publication Publié, 1976
;Vander Linden, M.P.Référence Arzneimittel-Forschung, 26, 2, page (184-185)
Publication Publié, 1976
Article révisé par les pairs
| Résumé : | The study of the inhibitory activity of ribostamycin (Vistamycin), an antibiotic derived from Streptomyces ribosidificus, on 161 strains of Gram negative bacilli shows that the antibacterial spectrum of this antibiotic is identical to that of kanamycin. If controlled clinical studies confirm that ribostamycin is less toxic than kanamycin on the otovestibular system, this antibiotic will constitute a real therapeutic advance. |
